(주)큐라클

{
  "address": "서울특별시 서초구",
  "ceo_name": "유재현",
  "certificate": [
    {
      "cert_number": "20160300500",
      "changes": "",
      "disclosure_date": "2016-11-01",
      "first_cert_date": "2016-11-01",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2016-11-01 ~ 2018-10-31"
    },
    {
      "cert_number": "20180300756",
      "changes": "",
      "disclosure_date": "2018-11-15",
      "first_cert_date": "2016-11-01",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2018-11-01 ~ 2020-10-31"
    },
    {
      "cert_number": "20200301199",
      "changes": "",
      "disclosure_date": "2020-10-22",
      "first_cert_date": "2016-11-01",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2020-11-01 ~ 2022-10-31"
    },
    {
      "cert_number": "20221116020004",
      "changes": "",
      "disclosure_date": "2022-11-16",
      "first_cert_date": "2016-11-01",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2022-11-01 ~ 2025-10-31"
    },
    {
      "cert_number": "20251029020001",
      "changes": "",
      "disclosure_date": "2025-10-29",
      "first_cert_date": "2016-11-01",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2025-11-01 ~ 2028-10-31"
    }
  ],
  "company_name": "주식회사 큐라클",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 6922984000,
      "cost_of_sales": 0,
      "current_assets": 33406558000,
      "current_liabilities": 1370678000,
      "gross_profit": 3582859000,
      "net_income": -11405592000,
      "net_income_bs": -11405593000,
      "non_current_assets": 22250915000,
      "non_current_liabilities": 8116068000,
      "non_operating_expenses": 555244000,
      "non_operating_income": 1131863000,
      "operating_profit": -11982211000,
      "revenue": 3582859000,
      "sga_expenses": 15565070000,
      "total_assets": 55657473000,
      "total_equity": 46170727000,
      "total_liabilities": 9486746000
    },
    "2023": {
      "capital_stock": 6927671000,
      "cost_of_sales": 0,
      "current_assets": 44473450000,
      "current_liabilities": 10196545000,
      "gross_profit": 10294391000,
      "net_income": -11585769000,
      "net_income_bs": -11585769000,
      "non_current_assets": 25308683000,
      "non_current_liabilities": 17722411000,
      "non_operating_expenses": 2802448000,
      "non_operating_income": 1724789000,
      "operating_profit": -10508110000,
      "revenue": 10294391000,
      "sga_expenses": 20802501000,
      "total_assets": 69782133000,
      "total_equity": 41863176000,
      "total_liabilities": 27918957000
    },
    "2024": {
      "capital_stock": 6936984000,
      "cost_of_sales": 0,
      "current_assets": 32417333000,
      "current_liabilities": 20986484000,
      "gross_profit": 1632550000,
      "net_income": -14886473000,
      "net_income_bs": -14886473000,
      "non_current_assets": 26871034000,
      "non_current_liabilities": 8348547000,
      "non_operating_expenses": 4531302000,
      "non_operating_income": 2279517000,
      "operating_profit": -12634688000,
      "revenue": 1632550000,
      "sga_expenses": 14267238000,
      "total_assets": 59288367000,
      "total_equity": 29953335000,
      "total_liabilities": 29335032000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "3,499,957,000",
      "changes": "3,499,957,000",
      "date": "2019-10-25"
    }
  ],
  "main_products": "의약품 개발",
  "phone": "02-3487-****",
  "years": [
    2024,
    2023,
    2022
  ]
}